Tat as a transcriptional activator and a potential therapeutic target for HIV-I

Advances in Pharmacology

Volumn 48, Issue , 2000, Pages 209-227

  Gatignol, Anne ^a,b   Jeang, Kuan Teh ^c  

^a INSTITUT COCHIN   (France)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CCNT1 PROTEIN, HUMAN; CYCLINE; HISTONE ACETYLTRANSFERASE; RNA BINDING PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; TRANS ACTIVATION RESPONSIVE RNA BINDING PROTEIN; TRANS-ACTIVATION RESPONSIVE RNA-BINDING PROTEIN; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG ANTAGONISM; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; REVIEW; TRANSACTIVATION; VIRUS REPLICATION;

ACETYLTRANSFERASES; ACQUIRED IMMUNODEFICIENCY SYNDROME; CYCLINS; GENE PRODUCTS, TAT; HISTONE ACETYLTRANSFERASES; HIV-1; HUMANS; RNA-BINDING PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 0034565451     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s1054-3589(00)48007-5     Document Type: Article

References (148)

1. F. About-ela J. Karn G. Vatani Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge Nucleic Acids Res. 24 1996 3974 3981
2. E. Aguilar-Cordova J. Chinen L. Donehower J. Harper A. Rice J. Butel J. Belmont Inhibition of HIV-1 by a double transdominant fusion gene Gene Ther. 2 1995 181 186
3. J. Allen M. Walberg M. Edwards S. Elledge Finding prospective partners in the library: The two-hybrid system and phage display find a match Trends Biochem. Sci. 20 1995 511 516
4. A. Alonso T.P. Cujec B.M. Peterlin Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1 J. Virol. 68 1994 6505 6513
5. A. Alonso D. Derse B. Peterlin Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells J. Virol. 66 1992 4617 4621
6. HIV Tat inhibitor from Allelix entering clinical Trials Anonymous Antiviral Agents Bull. 6 1993 130 131
7. P.A. Barry E. Pratt-Lowe R.E. Unger P.A. Luciw Cellular factors regulate transactivation of human immunodeficiency virus type 1 J. Virol. 65 1991 1392 1399
8. M. Benkirane R.F. Chun H. Xiao V.V. Ogryzko B.H. Howard Y. Nakatani K.T. Jeang Activation of integrated provirus requires histone acetyltransferase: p300 and P/CAF are coactivators for HIV-1 Tat J. Biol. Chem. 273 1998 24898 24905
9. M. Benkirane C. Neuveut R. Chun S. Smith C. Samuel A. Gatignol K.-T. Jeang Oncogenic potential of TAR RNA-binding protein TRBP and its regulatory interaction with Protein Kinase PKR EMBO J. 16 1997 611 624
10. B. Berkhout A. Gatignol A.B. Rabson K.-T. Jeang TAR-independent activation of the HIV-1 LTR: Evidence that Tat requires specific regions of the promoter Cell 62 1990 757 767
11. B. Berkhout K.-T. Jeang Detailed analysis of TAR RNA: Critical spacing between the bulge and loop recognition domains Nucleic Acids Res. 19 1991 6169 6176
12. B. Berkhout K.-T. Jeang Trans-activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-actingresponsive hairpin: A quantitative analysis J. Virol. 63 1989 5501 5504
13. B. Berkhout R.H. Silverman K.-T. Jeang Tat trans-activates the human immunodeficiency virus through a nascent RNA target Cell 59 1989 273 282
14. P.D. Bieniasz T.A. Grdina H.P. Bogerd B.R. Cullen Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat EMBO J. 17 1998 7056 7065
15. E. Blair C. Roberts B. Snowden A. Gatignol M. Benkirane K.-T. Jeang Expression of TAR RNA-binding protein in baculovirus and co-immunoprecipitation with insect cell protein kinase J. Biomed. Sci. 2 1995 322 329
16. J. Blau H. Xiao S. McCracken P. O'Hare J. Greenblatt D. Bentley Three functional classes of transcriptional activation domain Mol. Cell. Biol. 16 1996 2044 2055
17. H. Chang R. Gendelman J. Lisziewicz R. Gallo B. Ensoli Block of HIV-1 infection by a combination of antisensé tat RNA and TAR decoys: A strategy for control of HIV-1 Gene Ther. 1 1994 208 216
18. L. Chang C. Zhang Infection and replication of Tat- human immunodeficiency viruses: Genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells Virology 211 1995 157 169
19. D. Chen Q. Zhou Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase Mol. Cell. Biol 19 1999 2863 2871
20. C.M. Chiang R.G. Roeder Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators Science 267 1995 531 536
21. R.F. Chun K.T. Jeang Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1 J. Biol. Chem. 271 1996 27888 27894
22. R.F. Chun O.J. Semmes C. Neuveut K.T. Jeang Modulation of Sp 1 phosphorylation by human immunodeficiency virus type 1 Tat J. Virol. 72 1998 2615 2629
23. R. Cortese P. Monaci A. Luzzago C. Santini F. Bartoli L. Cortese P. Fortugno G. Galfre A. Nicosia F. Felici Selection of biologically active peptides by phage display of random peptide libraries Curr. Opin. Biotechnol. 7 1996 616 621
24. G.P. Cosentino S. Venkatesan F.C. Serluca S.R. Green M.B. Mathews N. Sonenberg Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo Proc. Natl. Acad. Sci. USA 92 1995 9445 9449
25. T.P. Cujec H. Cho E. Maldonado J. Meyer D. Reinberg B.M. Peterlin The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme Mol. Cell. Biol. 17 1997 1817 1823
26. T.P. Cujec H. Okamoto K. Fujinaga J. Meyer H. Chamberlin D.O. Morgan B.M. Peterlin The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II Genes Dev. 11 1997 2645 2657
27. L. Cupelli M. Hsu The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter J. Virol. 69 1995 2640 2643
28. M.E. Dahmus Reversible phosphorylation of the C-terminal domain of RNA polymerase II J. Biol. Chem. 271 1996 19009 19012
29. P. Dal Monte M.P. Landini J. Sinclair J.L. Virelizier S. Michelson TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cyromegalovirus IE1/IE2 AIDS 11 1997 297 303
30. L. Dassonneville F. Hamry P. Colson C. Houssier C. Bailly Binding of Hoechst 33258 to the TAR RNA of HIV-1: Recognition of a pyrimidine bulge-dependent structure Nucleic Acids Res. 25 1997 4487 4492
31. L. Daviet F. Bois P.-L. Battisti A. Gatignol Identification of limiting steps for efficient trans-activation of HIV-1 promoter by Tat in Saccharomyces cerevisiae J. Biol. Chem. 273 1998 28219
32. L. Daviet M. Erard D. Dorin M. Duarte C. Vaquero A. Gatignol The analysis of a binding difference between the two dsRNA-binding domains in TRBP reveals the modular function of a KR-helix motif Eur. J. Bioch. 267 2000 2419 2431
33. A.L. Dayton J. Sodroski C. Rosen W. Goh W. Haseltine The trans-activator gene of the human T cell lymphotropic virus type III is required for replication Cell 44 1986 941 947
34. E. De Clercq Antiviral therapy for human immunodeficiency virus infections Clin. Microbiol. Rev. 8 1995 200 239
35. E. De Clercq Carbocyclic adenosine analogues as S -adenosylhomocysteine hydrolase inhibitors and antiviral agents: Recent advances Nucleosides Nucleotides 17 1998 625 634
36. U. Delling S. Roy M. Sumner-Smith R. Barnett L. Reid C.A. Rosen N. Sonenberg The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA Proc. Natl. Acad. Sci. USA 88 1991 6234 6238
37. D. Derse M. Carvalho R. Carroll B.M. Peterlin A minimal lentivirus Tat J. Virol. 65 1991 7012 7015
38. C. Dingwall I. Ernberg M. Gait S. Green S. Heaphy J. Karn A. Lowe M. Singh M. Skinner HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure EMBO J. 9 1990 4145 4153
39. B.J. Doranz K. Grovit-Ferbas M.P. Sharron S.H. Mao M.B. Goetz E.S. Daar R.W. Doms W.A. O'Brien A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor J. Exp. Med. 186 1997 1395 1400
40. M. Erard D. Barker F. Amalric K.-T. Jeang A. Gatignol An Arg/Lys-rich core peptide mimics TRBP binding to the HIV-1 TAR RNA upper-stem/loop J. Mol. Biol. 279 1998 1085 1099
41. M. Feinberg D. Baltimore A. Frankel The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation Proc. Natl. Acad. Sci. USA 88 1991 4045 4049
42. S. Feng E.C. Holland HIV-1 tat trans-activation requires the loop sequence within tar Nature 334 1988 165 167
43. C. Fraisier D. Abraham M. van Oijen V. Cunliffe A. Irvine R. Craig E. Dzierzak Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins Gene Ther. 5 1998 946 954
44. K. Fujinaga R. Taube J. Wimmer T.P. Cujec B.M. Peterlin Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T Proc. Natl. Acad. Sci. USA 96 1999 1285 1290
45. M.E. Garber P. Wei V. KewalRamani T.P. Mayall C. Herrmann A.P. Rice D.R. Littman K. Jones The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein Genes Dev. 12 1998 3512 3527
46. L.F. García-Martinez D. Ivanov R.B. Gaynor Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes J. Biol. Chem. 272 1997 6951 6958
47. L.F. García-Martinez G. Mavankal J.M. Neveu W.S. Lane D. Ivanov R.B. Gaynor Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription EMBO J. 16 1997 2836 2850
48. A. Gatignol C. Buckler K.-T. Jeang Relatedness of an RNA binding motif in HIV-1 TAR RNA binding protein TRBP to human P1/dsI kinase and Drosophila staufen Mol. Cell. Biol. 13 1993 2193 2202
49. A. Gatignol A. Buckler-White B. Berkhout K.-T. Jeang Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR Science 251 1991 1597 1600
50. A. Gatignol M. Duarte L. Daviet Y.-N. Chang K.-T. Jeang Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors Gene Expr. 5 1996 217 228
51. A. Gatignol K.-T. Jeang Expression cloning of genes encoding RNA binding proteins K.W. Adolph Methods in Molecular Genetics: Molecular Virology Techniques A 1994 Academic Press San Diego, CA 18 28
52. M. Gold X. Yang C. Herrmann A. Rice PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo J. Virol. 72 1998 4448 4453
53. P.R. Gorry J.L. Howard M.J. Churchill J.L. Anderson A. Cunningham D. Adrian D.A. McPhee D.F. Purcell Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev J. Virol. 73 1999 352 361
54. M.R. Green Molecular mechanisms of Tat and Rev AIDS Res. Rev. 3 1993 41 55
55. C. Gregoire E. Loret Conformational heterogeneity in two regions of TAT results in structural variations of this protein as a function of HIV-1 isolates J. Biol. Chem. 271 1996 22641 22646
56. S. Hahn Activation and the role of reinitiation in the control of transcription by RNA polymerase II Cold Spring Harb. Symp. Quant. Biol. 63 1998 181 188
57. F. Hamy V. Brondani A. Florsheimer W. Stark M.J. Blommers T. Kilmkait A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition Biochemistry 37 1998 5086 5095
58. F. Hamy E.R. Felder G. Heizmann J. Lazdins F. Aboul-ela G. Varani J. Karn T. Klimkait An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication Proc. Natl. Acad. Sci. USA 94 1997 3548 3553
59. D. Harrich J. Garcia R. Mitsuyasu R. Gaynor TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes EMBO J. 9 1990 4417 4423
60. C. Hart J. Galphin M. Westhafer G. Schochetman TAR loop-dependant human immunodeficiency virus trans activation requires factors encoded on human chromosome 12 J. Virol. 67 1993 5020 5024
61. C. Hart C.-Y. Ou J. Galphin J. Moore L. Bacheler J. Wasmuth S. Petteway G. Schochetman Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells Science 246 1989 488 491
62. C.H. Herrmann A.P. Rice Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor J. Virol. 69 1995 1612 1620
63. F.C. Holstege U. Fiedler H.T. Timmers Three transitions in the RNA polymerase II transcription complex during initiation EMBO J. 16 1997 7468 7480
64. M.O. Hottiger G.J. Nabel Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein J. Virol. 72 1998 8252 8256
65. M.-C. Hsu A.D. Schmutt M. Holly L.W. Slice M.I. Sherman D.D. Richman M.J. Potash D.J. Volsky Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist Science 254 1991 1799 1802
66. J.R. Hwu W.N. Tseng J. Gnabre P. Giza R.C. Huang Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation J. Med. Chem. 41 1998 2994 3000
67. A. Jakobovits D.H. Smith E.B. Jakobovits D.J. Capon A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator Mol. Cell. Biol. 8 1988 2555 2561
68. K. Jeang B. Berkhout B. Dropulic Effects of integration and replication on transcription of the HIV-1 long terminal repeat J. Biol. Chem. 268 1993 24940 24949
69. K.-T. Jeang Tat, Tat-associated kinase, and transcription J. Biomed. Sci. 5 1998 24 27
70. K.-T. Jeang B. Berkhout Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps J. Biol. Chem. 267 1992 17891 17899
71. K.-T. Jeang R. Chun N.H. Lin A. Gatignol C.G. Glabe H. Fan In vitro and in vivo binding of human immunodeficiency virus type 1 tat protein and Spl transcription factor J. Virol. 67 1993 6224 6233
72. K.-T. Jeang P.R. Shank A. Kumar Transcriptional activation of homologous viral long terminal repeats by the human immunodeficiency virus type 1 or the human T-cell leukemia virus type I tat proteins occurs in the absence of de novo protein synthesis Proc. Natl. Acad. Sci. USA 85 1988 8291 8295
73. K.-T. Jeang H. Xiao E. Rich Multifaceted activities of the human immunodeficiency virus type 1 transactivator of transcription, Tat J. Biol. Chem. 274 1999 28837 28840
74. K. Jones B. Peterlin Control of RNA initiation and elongation at the HIV-1 promoter Annu. Rev. Biochem. 63 1994 717 743
75. K.A. Jones Taking a new TAK on tat transactivation Genes Dev. 11 1997 2593 2599
76. J. Kamine T. Subramanian G. Chinnadurai Activation of a heterologous promoter by HIV 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators J. Virol. 67 1993 6828 6834
77. J. Kamine T. Subramanian G. Chinnadurai Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein Proc. Natl. Acad. Sci. USA 88 1991 8510 8514
78. S. Kao A. Calman P. Luciw B. Peterlin Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product Nature 330 1987 489 493
79. F. Kashanchi G. Piras M.F. Radonovich J.F. Duvall A. Fattaey C.-M. Chiang R.G. Roeder J.N. Brady Direct interaction of human TFIID with the HIV-1 transactivator Tat Nature 367 1994 295 299
80. N.J. Keen M.J. Churcher J. Karn Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex EMBO J. 16 1997 5260 5272
81. N.J. Keen M.J. Gait J. Karn Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex Proc. Natl. Acad. Sci. USA 93 1996 2505 2510
82. Y.S. Kim R. Risser TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein J. Virol. 67 1993 239 248
83. S.M. Kingsman A.J. Kingsman The regulation of human immunodeficiency virus type-1 gene expression Eur. J. Biochem. 240 1996 491 507
84. B. Klaver B. Berkhout Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus EMBO J. 13 1994 2650 2659
85. B. Korber B. Hahn B. Foley J. Mellors T. Leitner G. Myers F. McCutchan C. Kuiken B. Korber B. Hahn B. Foley J.W. Mellors T. Leitner G. Myers F. McCutchan C. Kuiken A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences 1997 Los Alamos National Laboratory Los Alamos, NM
86. C. Kozak A. Gatignol K. Graham K.-T. Jeang O. McBride Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1) Genomics 25 1995 66 72
87. K.P. Kumar S. Akoulitchev D. Reinberg Promoter-proximal stalling results from the inability to recruit transcription factor IIH to the transcription complex and is a regulated event Proc. Natl. Acad. Sci. USA 95 1998 9767 9772
88. Y. Kwak D. Ivanov J. Guo E. Nee R. Gaynor Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation J. Mol. Biol. 288 1999 57 69
89. M. Laspia A. Rice M. Mathews HIV-1 tat protein increases transcriptional initiation and stabilizes elongation Cell 59 1989 283 292
90. J. Lis Promoter-associated pausing in promoter architecture and postinitiation transcriptional regulation Cold Spring Harb. Symp. Quant. Biol. 63 1998 347 356
91. J. Lisziewicz D. Sun B. Trapnell M. Thomson H. Chang B. Ensoli B. Peng An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy J. Virol. 69 1995 206 212
92. K. Long D. Crothers Characterization of the solution conformations of unbound and tat peptide-bound forms of HIV-1 TAR RNA Biochemistry 38 1999 10059 10069
93. H.S. Mancebo G. Lee J. Flygare J. Tomassini P. Luu Y. Zhu J. Peng C. Blau D. Hazuda D. Price O. Flores P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro Genes Dev. 11 1997 2633 2644
94. G. Marzio M. Tyagi M.I. Gutierrez M. Giacca HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter Proc. Natl. Acad. Sci. USA 95 1998 13519 13524
95. S. McCracken N. Fong K. Yankulov S. Ballantyne G. Pan J. Greenblatt S.D. Patterson M. Wickens D.L. Bentley The C-terminal domain of RNA polymerase II couples mRNA processing to transcription Nature 385 1997 357 361
96. E. Meurs K. Chong J. Galabru N. Thomas I. Kerr B. Williams A. Hovanessian Molecular cloning and characterization of the human double-stranded RNAactivated protein kinase induced by interferon Cell 62 1990 379 390
97. W. Michne J. Schroeder T. Bailey H. Neumann D. Cooke D. Young J. Hughes S. Kingsley R. Ka H. Putz L. Shaw F. Dutko Keto/enol epoxy steroids as HIV1 Tat inhibitors: Structure-activity relationships and pharmacophore localization J. Med. Chem. 38 1995 3197 3206
98. S. Nekhai R.R. Shukla A. Kumar A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the Cterminal domain of RNA polymerase II and induces CAK activity J. Virol. 71 1997 7436 7441
99. C. Neuveut K.-T. Jeang Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture J. Virol. 70 1996 5572 5581
100. M. Newstein I.S. Lee D. Venturini P. Shank A chimeric human immunodeficiency virus type 1 TAR region which mediates high level trans-activation in both rodent and human cells Virology 197 1993 825 828
101. M. Newstein E. Stanbridge G. Casey P. Shank Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells J. Virol. 64 1990 4565 4567
102. W.A. O'Brien M. Sumner-Smith S.H. Mao S. Sadeghi J.Q. Zhao I.S. Chen Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions J. Virol. 70 1996 2825 2831
103. H. Okamoto C.T. Sheline J.L. Corden K.A. Jones B.M. Peterlin Transactivation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II Proc. Natl. Acad. Sci. USA 93 1996 11575 11579
104. A.S. Pagtakhan S.E. Tong-Starksen Interactions between Tat of HIV-2 and transcription factor Spl Virology 238 1997 221 230
105. C.A. Parada R.G. Roeder Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain Nature 384 1996 375 378
106. H. Park M. Davies J. Langland H.-W. Chang Y.S. Nam J. Tartaglia E. Paoletti B. Jacobs R. Kaufman S. Venkatesan TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR Proc. Natl. Acad. Sci. USA 91 1994 4713 4717
107. P.S. Pendergrast N. Hernandez RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat J. Virol. 71 1997 910 917
108. J. Peng Y. Zhu J.T. Milton D.H. Price Identification of multiple cyclin subunits of human P-TEFb Genes Dev. 12 1998 755 762
109. F. Pessler N. Hernandez The HIV-1 inducer of short transcripts activates the synthesis of 5,6-dichloro-1-beta- d -benzimidazole-resistant short transcripts in vitro J. Biol. Chem. 273 1998 5375 5384
110. Y.H. Ping T.M. Rana Tat-associated kinase (P-TEFb): A component of transcription preinitiation and elongation complexes J. Biol. Chem. 274 1999 7399 7404
111. W. Popik P. Pitha Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1 J. Virol. 67 1993 1094 1099
112. T. Rana K.-T. Jeang Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA Arch. Biochem. Biophys. 365 1999 175 185
113. T.R. Reddy M. Suhasini J. Rappaport D.J. Looney G. Kraus F. Wong-Staal Molecular cloning and characterization of a TAR-binding nuclear factor from T cells AIDS Res. Hum. Retroviruses 11 1995 663 669
114. D. Reinberg G. Orphanides R. Ebright S. Akoulitchev J. Carcamo H. Cho P. Cortes R. Drapkin O. Flores I. Ha J.A. Inostroza S. Kim T.K. Kim P. Kumar T. Lagrange G. LeRoy H. Lu D.M. Ma E. Maldonado A. Merino F. Mermelstein I. Olave M. Sheldon R. Shiekhattar N. Stone X. Sun L. Weis K. Yeung L. Zawel The RNA polymerase 11 general transcription factors: past, present, and future Cold Spring Harb. Symp. Quant. Biol. 63 1998 83 103
115. U. Reineke R. Sabat R. Misselwitz H. Welfle H. Volk J. Schneider-Mergener A synthetic mimic of a discontinuous binding site on interleukin-10 Nat. Biotechnol. 17 1999 271 275
116. M.P. Rounseville H.C. Lin E. Agbottah R.R. Shukla A.B. Rabson A. Kumar Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures Virology 216 1996 411 417
117. S. Roy N. Parkin C. Rosen J. Itovitch N. Sonenberg Structural requirements for trans-activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: Importance of base pairing, loop sequence, and bulges in the tatresponsive sequence J. Virol. 64 1990 1402 1406
118. L.J. Seigel L. Ratner S.F. Josephs D. Derse M.B. Feinberg G.R. Reyes S.J. O'Brien F. Wong-Staal Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity Virology 148 1986 226 231
119. M. Selby E. Bain P. Luciw B. Peterlin Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat Genes Dev. 3 1989 547 558
120. M. Selby B. Peterlin Trans-activation by HIV-1 Tat via a heterologous RNA binding protein Cell 62 1990 769 776
121. M. Sheldon R. Ratnasabapathy N. Hernandez Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs Mol. Cell. Biol. 13 1993 1251 1263
122. P. Sheridan T. Mayall E. Verdin K. Jones Histone acetyltransferases regulate HIV-1 enhancer activity in vitro Genes Dev. 11 1997 3327 3340
123. C. Southgate M.L. Zapp M.R. Green Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein Nature 345 1990 640 642
124. C.D. Southgate M.R. Green Delineating minimal protein domains and promoter elements for transcriptional activation by lentivirus Tat proteins J. Virol. 69 1995 2605 2610
125. C.D. Southgate M.R. Green The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: Implications for Tat function Genes Dev. 5 1991 2496 2507
126. D. St Johnston N.H. Brown J.G. Gall M. Jantsch A conserved doublestranded RNA-binding domain Proc. Natl. Acad. Sci. USA 89 1992 10979 10983
127. J. Taylor R. Pomerantz O. Bagasra M. Chowdhury J. Rappaport K. Khalili S. Amini TAR-independent transactivation by Tat in cells derived from the CNS: A novel mechanism of HIV-1 gene regulation EMBO J. 11 1992 3395 3403
128. P. Thatikunta B.E. Sawaya L. Denisova C. Cole G. Yusibova E.M. Johnson K. Khalili S. Amini Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells J. Cell. Biochem. 67 1997 466 477
129. R. Toyama S.M. Bende R. Dhar Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe Nucleic Acids Res. 20 1992 2591 2596
130. C. Van Lint S. Emiliani M. Ott E. Verdin Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation EMBO J. 15 1996 1112 1120
131. E. Verdin J. Paras C. Van Lint Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation EMBO J. 12 1993 3249 3259
132. K. Verhoef B. Berkhout A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus J. Virol. 73 1999 2781 2789
133. K. Verhoef M. Tijms B. Berkhout Optimal Tat-mediated activation of the HIV1 LTR promoter requires a full-length TAR RNA hairpin Nucleic Acids Res. 25 1997 496 502
134. P. Veschambre P. Simard P. Jalinot Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo J. Mol. Biol. 250 1995 169 180
135. P. Wei M.E. Garber S.M. Fang W.H. Fischer K.A. Jones A novel CDK9associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA Cell 92 1998 451 462
136. J.D. Weissman J.A. Brown T.K. Howcroft J. Hwang A. Chawla P.A. Roche L. Schiltz Y. Nakatani D.S. Singer HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes Proc. Natl. Acad. Sci. USA 95 1998 11601 11606
137. D. Wilson B. Finlay Phage display: applications, innovations, and issues in phage and host biology Can. J. Microbiol. 44 1998 313 329
138. F. Wu-Baer W.S. Lane R.B. Gaynor The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA EMBO J. 14 1995 5995 6009
139. F. Wu-Baer D. Sigman R.B. Gaynor Specific binding of RNA polymerase 11 to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat Proc. Natl. Acad. Sci. USA 92 1995 7153 7157
140. H. Xiao J.T. Lis K.-T. Jeang Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment Mol. Cell. Biol. 17 1997 6898 6905
141. X. Yang M.O. Gold D.N. Tang D.E. Lewis E. Aguilar-Cordova A.P. Rice C.H. Herrmann TAK, an HIV Tat-associated kinase, is a member of the cyclindependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines Proc. Natl. Acad. Sci. USA 94 1997 12331 12336
142. X. Yang C.H. Herrmann A.P. Rice The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function J. Virol. 70 1996 4576 4584
143. K. Yankulov D. Bentley Transcriptional control: Tat cofactors and transcriptional elongation Curr. Biol. 8 1998 R447 449
144. L. Yu P.M. Loewenstein Z. Zhang M. Green In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP J. Virol. 69 1995 3017 3023
145. L. Yu Z. Zhang P.M. Loewenstein K. Desai Q. Tang D. Mao J.S. Symington M. Green Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain J. Virol. 69 1995 3007 3016
146. Q. Zhou P.A. Sharp Novel mechanism and factor for regulation by HIV-1 Tat EMBO J. 14 1995 321 328
147. Q. Zhou P.A. Sharp Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat Science 274 1996 605 610
148. Y. Zhu T. Pe'ery J. Peng Y. Ramanathan N. Marshall T. Marshall B. Amendt M.B. Mathews D.H. Price Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro Genes Dev. 11 1997 2622 2632